for the Period Ended 31 December 2023
Profit and loss | |
Balance sheet | |
Additional notes | |
Balance sheet notes | |
Community Interest Report |
for the Period Ended
2023 | 2022 | |
---|---|---|
| £ | £ |
Turnover: | | |
Cost of sales: | ( | |
Gross profit(or loss): | | |
Administrative expenses: | ( | ( |
Operating profit(or loss): | | ( |
Profit(or loss) before tax: | | ( |
Profit(or loss) for the financial year: | | ( |
As at
Notes | 2023 | 2022 | |
---|---|---|---|
| £ | £ | |
Current assets | |||
Cash at bank and in hand: | | | |
Total current assets: | | | |
Creditors: amounts falling due within one year: | 3 | ( | ( |
Net current assets (liabilities): | | | |
Total assets less current liabilities: | | | |
Accruals and deferred income: | ( | ||
Total net assets (liabilities): | | ( | |
Members' funds | |||
Profit and loss account: | | ( | |
Total members' funds: | | ( |
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 December 2023
Basis of measurement and preparation
for the Period Ended 31 December 2023
2023 | 2022 | |
---|---|---|
Average number of employees during the period | | |
for the Period Ended 31 December 2023
2023 | 2022 | |
---|---|---|
£ | £ | |
Bank loans and overdrafts | | |
Accruals and deferred income | | |
Other creditors | | |
Total | | |
Plant Based Health Online (PBHO) C.I.C has a small team of healthcare professionals who undertake remote consultations (on a 1:1 individual basis as well as group consultations) with patients to manage their chronic disease eg type 2 diabetes, heart disease as well as support patients through their cancer journey and menopause. PBHO continues to work with cancer charities to support these programmes in order to optimise our patients health outcomes.
PBHO asks for patient feedback (by questionnaire) on a regular basis and have invited patients for focus group work to improve our services. We have adapted our consultations methods according to their feedback and have also reviewed wording on our website. Our patient feedback has been sent to stakeholders. We have a bidirectional relationship with many of our stakeholders where they have helped us, provided feedback and we have provided educational resources and other teaching materials to support their work too (eg flyers, webinars, factsheets etc).
Monthly director fee £750
No transfer of assets other than for full consideration
This report was approved by the board of directors on
8 February 2024
And signed on behalf of the board by:
Name: Laura Freeman
Status: Director